Correlation Between Centessa Pharmaceuticals and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Inhibikase Therapeutics, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Inhibikase Therapeutics.
Diversification Opportunities for Centessa Pharmaceuticals and Inhibikase Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Centessa and Inhibikase is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Inhibikase Therapeutics
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 0.67 times more return on investment than Inhibikase Therapeutics. However, Centessa Pharmaceuticals PLC is 1.5 times less risky than Inhibikase Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 819.00 in Centessa Pharmaceuticals PLC on August 28, 2024 and sell it today you would earn a total of 891.00 from holding Centessa Pharmaceuticals PLC or generate 108.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Inhibikase Therapeutics |
Centessa Pharmaceuticals and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Inhibikase Therapeutics
The main advantage of trading using opposite Centessa Pharmaceuticals and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.The idea behind Centessa Pharmaceuticals PLC and Inhibikase Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |